Robert Kramer, EVP, Corporate Services Divisi at Emergent BioSolutions Inc. (EBS), sold 84,844 shares at $35.49 ($3.0M) on 2016-04-01, disclosed to the SEC on 2016-04-05.
Open-market sale of $3.0M EBS by EVP, Corporate Services Divisi. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.48 | 17,354 | $616K | 20.4% |
| 2 | $35.48 | 17,354 | $616K | 20.4% |
| 3 | $35.49 | 11,531 | $409K | 13.6% |
| 4 | $35.49 | 11,531 | $409K | 13.6% |
| 5 | $35.66 | 5,503 | $196K | 6.5% |
| 6 | $35.66 | 5,503 |
| $196K |
| 6.5% |
| 7 | $35.73 | 2,945 | $105K | 3.5% |
| 8 | $35.73 | 2,945 | $105K | 3.5% |
| 9 | $35.74 | 3,939 | $141K | 4.7% |
| 10 | $35.74 | 3,939 | $141K | 4.7% |
| 11 | $35.80 | 1,855 | $66K | 2.2% |
| 12 | $35.93 | 445 | $16K | 0.5% |
| Total | $35.56 avg | 84,844 | $3.0M | 100% |
| Filing → |
| EBS | SELL | 2021-01-19 | $4.0M | — | Filing → |
| EBS | SELL | 2016-04-08 | $847K | — | Filing → |
| EBS | SELL | 2016-04-05 | $804K | — | Filing → |